WHO ICTRP trial
MOVE SMART – a feasibility study in patients with psoriasis
ISRCTN17400289 · International Standard Randomised Controlled Trial Number (ISRCTN) · Recruiting
Key facts
| Trial ID | ISRCTN17400289 |
|---|---|
| Public title | MOVE SMART – a feasibility study in patients with psoriasis |
| Scientific title | MOVE SMART – a feasibility study to assess design of a randomised controlled clinical trial of a sedentary interruption intervention to improve health outcomes for patients with psoriasis |
| Primary sponsor | University of Manchester |
| Registry | International Standard Randomised Controlled Trial Number (ISRCTN) |
| Recruitment status | Recruiting |
| Study type | Interventional |
| Phase | Not Applicable |
| Countries | England;United Kingdom |
| Conditions | Psoriasis Skin and Connective Tissue Diseases |
| Interventions | The study will last 24 weeks. All volunteers will continue with their usual treatment and have an equal chance of being randomly allocated to the MOVE SMART group using a stratified randomisation procedure. MOVE SMART will last for 12… |
| Registration date | Nov 20, 2024 |
| Target size | 60 |
| Secondary IDs | Nil known;Nil known;CPMS 58898, NIHR207157 |
| Registry page | isrctn.com |
At a glance
- Yes Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: